Amira Johnson
About Amira Johnson
Amira Johnson is a Senior Territory Business Manager at Bristol Myers Squibb in Denver, Colorado, with a diverse background in medical sales and clinical research.
Title
Amira Johnson holds the position of Senior Territory Business Manager at Bristol Myers Squibb. She is currently based in Denver, Colorado.
Professional Background
Amira Johnson has a diverse professional background with experience spanning several key roles in the medical and pharmaceutical industries. Prior to her current position at Bristol Myers Squibb, she worked at Guerbet as Territory Sales Manager Interventional Imaging from 2018 to 2020. She has also held roles at TriSalus Life Sciences, including Clinical Research Associate from 2016 to 2018 and Interventional Radiology Manager from 2015 to 2016. Her earlier career includes positions such as Clinical Specialist ClearPoint US at BrainLab (2012-2015), Clinical Specialist at Veran Medical Technologies (2012), and Clinical Sales Specialist at Medtronic (2010-2012). She began her career as a cardiovascular sonographer at Rocky Mountain Cardiovascular Associates from 2008 to 2010.
Educational Background
Amira Johnson has a robust educational background. She earned a Bachelor of Science in Exercise Physiology from Florida State University. Additionally, she completed the Product Manager Certification at Product School in 2021. She also holds a Master of Business Administration (M.B.A.) from the UNC Kenan-Flagler Business School, having completed the Global OneMBA - Executive MBA Program from 2016 to 2018.
Achievements
During her tenure as Senior Territory Business Manager, Amira Johnson has achieved significant milestones. She ranked in the top 1% for sales performance by achieving 207% of the revenue goal in T3 2022. She also received an award for ranking in the 10th percentile in market share growth contest in T3 2022. Furthermore, her strategic initiatives, such as designing and executing a strategy for the Colorado Medicaid formulary opportunity, helped her achieve or exceed 100% of her revenue goal in multiple quarters from Q4 2021 to T1 2023.
Leadership in Innovation
Amira Johnson has contributed to innovation in the medical field. She was selected by her regional business director to join the Mavacamten Field Intelligence Team in 2021. This role involved focusing on product, disease state, and customer engagement strategies for the launch of CAMZYOS. Additionally, she led the business case development and vendor selection for new echo technologies in hypertrophic cardiomyopathy (HCM) care and explored the capabilities of AI-driven diagnostic tools for enhancing patient diagnosis, monitoring, and treatment.